Rayaldee pill Opko Health announced that the Food and Drug Administration (FDA) has approved Rayaldee (calcifediol) extended-release capsules for the treatment of secondary hyperparathyroidism (SHPT) ...
kidney Opko Health announced that Rayaldee (calcifediol) extended-release capsules will be available in pharmacies as early as Wednesday, November 30. Opko Health announced that Rayaldee (calcifediol) ...
OPKO’s newly approved extended-release capsule uses Catalent’s OptiShell softgel capsule technology. On June 21, 2016 FDA approved OPKO Health’s Rayaldee (calcifediol), an extended-release capsule for ...
NATIONAL HARBOR, Md.—An investigational treatment safely and effectively lowers elevated plasma intact parathyroid hormone (iPTH) levels in patients with stage 3 or 4 chronic kidney disease and ...
THE WOODLANDS, Texas--(BUSINESS WIRE)--Immunotec®, a global leader in health and wellness, proudly announces the launch of SunRay, a revolutionary Vitamin D supplement that combines the convenience of ...
Capsules offer certain benefits over tablets for oral-solid dosage drugs, and several types of capsules are available. Oral-solid dosage (OSD) drugs can be formulated in tablet or capsule form. Some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback